|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal Susitarimą)
| (51) | INT.CL. | C07H 21/04 | |
| C12N 5/12 | |||
| C07K 16/00 | |||
| A61K 39/395 | |||
| G01N 33/53 |
| (11) | Patento numeris | 2360169 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10184957.8 |
| Europos patento paraiškos padavimo data | 2002-10-23 | |
| (97) | Europos patento paraiškos paskelbimo data | 2011-08-24 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2015-10-14 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 335215 P | 2001-10-23 | US | |
| 362747 P | 2002-03-07 | US | |
| 412618 P | 2002-09-20 | US |
| (72) |
Maddon, Paul, US
Donovan, Gerald, US
Olson, William, US
Schulke, Norbert, US
Gardner, Jason, US
Ma, Dangshe, US
|
| (73) |
Psma Development Company, L.L.C.,
Progenics Pharmaceuticals, 777 Old Saw Mill River Road, Tarrytown, New York 10591,
US
|
| (54) | PSMA antibodies |
| PSMA antibodies |